Rapid screening of large numbers of swine sera for antibody is an essential element in the current eradication program for pseudorabies in the United States. We evaluated a recently introduced commercial semiautomated latex agglutination test (LAT) kit for pseudorabies antibody. A total of 1,191 swine sera were tested using the new procedure and 3 established tests: the manual LAT, the serum neutralization test (SNT), and an enzyme-linked immunosorbent assay (ELISA). There was close agreement among results of semiautomated LAT, the manual LAT, and ELISA but less agreement between semiautomated LAT and SNT. Overall, the sensitivities of the 4 tests were as follows: semiautomated LAT = manual LAT > ELISA > SNT. For 74 samples of known pseudorabies antibody status, the overall specificities were as follows: semi-automated LAT = manual LAT = SNT > ELISA. Because of its relative insensitivity, the SNT should no longer be considered the official "gold" standard for pseudorabies testing in the on-going eradication program. However, because no single test was perfect for all samples, a scheme including 3 tests in the following sequence is recommended: 1) screening using semiautomated LAT or ELISA and 2) confirmation testing of positives by manual LAT and SNT, with any sample that tests positive by any 2 tests being regarded as true positive.
Pseudorabies is caused by the pseudorabies virus
Recently, the same principle used in the manual LAT (PRV), 4 an alphaherpesvirus, and is an economically (i.e., agglutination of PRV antigen-coated latex partiimportant viral infection of swine in the United States cles in the presence of specific PRV antibody) was and many other countries. The economic impact of applied to the development of a semiautomated latex pseudorabies on the US swine industry is estimated to agglutination assay. b In the study described here, we be $21 million per year (Hallam JA et al., unpublished evaluated the ability of the semiautomated LAT to data). Swine constitute the main host and natural resdetect PRV antibody in field sera submitted for PRV ervoir of PRV. Pigs can become latently infected and diagnosis and in negative and positive control laboperiodically shed infectious virus particles into the enratory sera. The semiautomated LAT results were vironment; other species such as cattle, sheep, goats, compared with results from 3 other PRV antibody tests dogs, and cats that are susceptible to PRV usually ac-(manual LAT, ELISA, SNT) using the same sera. All quire a lethal infection and are therefore dead-end 4 tests are approved by the USDA for official pseuhosts. 4 dorabies testing. Strategies adopted for the control of pseudorabies rely on the knowledge that any pig that has contracted Materials and methods a primary infection can become latently infected and Serum samples. The 1,191 serum samples tested (Tables must therefore be considered a potential source of 1, 2) included 1,117 samples randomly selected from field transmission of infectious virus. Working on that sera submitted to our laboratory for routine PRV antibody premise, control of pseudorabies is primarily done by testing during the month of July 1994 (Table 1) then frozen; after thawing, they were sequentially tested by semiautomated LAT, manual LAT, and ELISA. The results of all 4 tests were read independently. Pseudorabies semiautomated LAT. The semiautomated LAT pseudorabies virus antibody test kit detects antibody to PRV. The test is based on the agglutination of PRV-coated polystyrene microspheres (latex particles) when mixed with PRV antibody. The agglutination reaction is performed in flat-bottom 96-well microtiter plates provided in the kit, and light transmittance is read at a wavelength of 690 nm using a spectrophotometer interfaced with a DOS-based microcomputer. d Two readings are made: an initial "blank" reading immediately after adding 25 µl volumes of 1:4 dilutions of sera to equal volumes of latex and a final reading after mixing on a plate rotator for 30 min. Negative and positive control sera are included in 3 replicate wells of each microplate. When latex particles agglutinate, the percentage of light transmitted through the well is increased. The computer calculates for each test well an agglutination index that expresses the relative amount of light transmitted through that well in comparison to the positive-negative differential. The higher the value of the agglutination index, the more positive the sample is considered to be. Index values > 8.0 are recorded as positive, values <4.5 are negative, and those between 4.5 and 8.0 are inconclusive (retest).
Comparison of the semiautomated LAT with established tests.
Results of the 4 serologic tests were compared by computing their sensitivities and specificities as follows. For field sera, the apparent sensitivity of each test was the percentage of samples that tested positive by that test. For check test sera, the sensitivity and specificity were the respective percentages of known positive and negative samples that were correctly identified by each procedure. Furthermore, the semiautomated LAT results were compared with manual LAT, ELISA, and SNT results by computing the agreement quotient (kappa) following established methods? Kappa expresses the level of agreement between 2 tests beyond that which is expected by chance alone and is therefore a true measure of agreement. Kappa values ≥ 0.5 are indicative of close agreement. 5 Western blotting. Western blotting was performed on 2 field samples that were positive by manual LAT, semiautomated LAT, and ELISA but negative by SNT. Procedure for western blotting was as described. 9 The rationale for using western blotting was to determine if the samples yielding discrepant results reacted with known PRV proteins.
Results
The comparative results using the 4 tests on field serum samples and the check test serum samples are presented in Tables 1 and 2 , respectively. Table 3 shows the sensitivities and specificities of the 4 tests, and Established tests. The semiautomated LAT was compared with 3 other USDA-approved official tests that are widely used: the manual LAT kit, b an indirect ELISA test kit, a and the SNT. The 2 commercial tests (manual LAT and ELISA) were performed following the manufacturers' instructions; the results were expressed as positive or negative. The SNT was performed according to the official protocol developed at the National Veterinary Services Laboratories 8 in a screening format (i.e., 1 dilution) to accommodate large-volume testing. For the SNT, 25 µl of each sample was added to duplicate wells of 96-well cell culture microplates. e Then 25 µl of the Shope strain of PRV diluted to contain 200 TCID 50 was added to each well, making a final serum dilution of 1:2. The plates were incubated for 1 hr at 37 C in 5% CO 2 , and then 150 µl of a pig kidney (PK-15) cell suspension containing 10 5 cells/ml was added to each well. The plates were incu- Table 4 presents the agreement quotients between the semiautomated LAT and the 3 other tests. Overall, there was close agreement among the results from all samples compared by semiautomated LAT, manual LAT, and ELISA ( K ≥ 0.92). There was less agreement between the results of the semiautomated LAT and the SNT (K = 0.81); the SNT detected fewer positives. The results for western blotting (Fig. 1 ) and the check test samples of known PRV antibody status (Table 2) indicate that most of the samples that were positive by the 3 other tests but negative by SNT contained PRV antibody. Indeed, 2 samples in this category reacted with PRV proteins gI (130 kD) and gIII (90 kD) by Western blotting (Fig. 1) .
The check test samples (Tables 2, 4) were drawn from 2 sources: 1992 and 1993 SNT check tests (n = 47) and 1993 ELISA/LAT check tests (n = 27). There was very close agreement among all 4 tests (K ≥ 0.95) for the samples standardized for SNT, but there was much less agreement between the semiautomated LAT and SNT result (K = 0.29) for samples standardized for ELISA and manual LAT (Table 4 ). For the latter group of samples, the results of manual LAT and semiautomated LAT agreed fully with expected results, and the ELISA produced positive results for 2 samples known to be negative and the SNT failed to detect 10 samples that were known to be positive. For the 47 SNT samples, 1 sample gave an inconclusive result by semiautomated LAT and 1 sample was positive by SNT, manual LAT, and semiautomated LAT but negative by ELISA.
When all 1,191 samples are considered, no single test gave a 100% satisfactory result. The SNT was less sensitive than the other tests (Table 3 ) and could not be used on 23 samples that were toxic and/or contaminated (Table 1 ). The manual LAT and semiautomated LAT gave 1 and 2 inconclusive results, respectively. The ELISA identified 2 samples as positive that were known to be antibody negative and failed to identify 1 sample that was positive by the other 3 procedures. 
Discussion
Previous studies comparing the performance of 3 of the PRV serology tests (manual LAT, ELISA, SNT) using sequential serum samples from pigs vaccinated or infected under experimental conditions have shown that their sensitivities decrease in the order LAT > ELISA > SNT. 2, 6, 7 In those studies, the manual LAT was more sensitive for detecting antibody early after vaccination or infection and as specific as either the ELISA or the SNT. Our results confirm those findings and also show that the semiautomated LAT is as sensitive and as specific as the manual LAT (Table 3) . The semiautomated LAT has the additional advantages over the manual LAT of being more accommodating for large numbers of samples and eliminating the element of subjectivity that is usually present when test results are read by the human eye.
Control and eradication programs for pseudorabies in the United States rely on serologic identification and elimination of infected pigs. The serologic procedures employed vary among states depending on the pseudorabies status of the pig population. In states such as Iowa and Indiana where the infection rate is currently high and vaccination is practiced, 1 serologic tests that can differentiate between vaccinated and infected pigs are used. Several ELISAs have been developed for that purpose and are commercially available. 6 In states such as Oklahoma (source of the field samples used in this running the ELISA, and Bob Naegele for help in western blot study) where the infection rate is very low and vacci-testing. The help of the entire staff in our serology laboratory nation is not practiced, simple screening tests are suf-is greatly appreciated. ficient. However, because of the low prevalence of antibodies in the pig populations in certain states, it is imperative that the most sensitive tests be used to make eradication of PRV an attainable goal. In this regard, our results and those of previous authors 2, 6, 7 show that the SNT cannot be relied upon as the definitive test for PRV antibody because of its relative insensitivity. The semiautomated LAT is at least as amenable to volume testing as is the ELISA, and it has the additional advantage over ELISA of being more rapid (30 minutes vs. 90 minutes, starting from the time samples are diluted).
Our data also show that no single test can be relied upon for PRV testing. In this study, the semiautomated LAT and manual LAT had 2 and 1 inconclusive results, respectively, the ELISA gave 2 false positives and 1 false negative, and the SNT was relatively insensitive. In view of these results, we propose that testing for PRV in states with a very low prevalence of PRV antibody be done using a combination of 3 tests as follows: 1) screen all samples by semiautomated LAT or ELISA and 2) test all positive and inconclusive samples by manual LAT and SNT. Any sample that yields a positive result in any 2 of the 3 tests should be regarded as positive, regardless of the SNT result. The procedural guidelines for official PRV testing in the eradication program should be reviewed. In particular, the SNT, because of its low sensitivity, should not be the only test for confirmation of positive results from other tests of proven superior sensitivity. Such a review is particularly relevant as more and more states move to stages III, IV, and V of the eradication program.
